semaglutide off the market India's obesity and diabetes drug is on verge of taking off. Semaglutide, the molecule behind Ozempic and Wegovy will go patent this Saturday paving the way for low-cost generic drugs Ozempic's biggest side effect: Turning

Eli Lillys December 2025 press release reported average weight loss of up to 71.2 lbs at the highest dose, alongside substantial relief from osteoarthritis pain

Repurposing ketamine to treat cocaine use disorder: integration of artificial intelligence-based prediction, expert evaluation, clinical corroboration and mechanism of action analyses

Improved HbA1c levels of less than 7 and weight loss of more than 5% of the usual body weight were observed in those who took the pill

Professor Lawley took this opportunity to share research he had conducted using mathematical modelling to address questions in this area

What is ipamorelin, and why is its selectivity clinically significant